[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356499-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356499-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-gp73-in-predicting-overall-survival-and-chemotherapy-response-in-locally-advanced-gastric-cancer-a-retrospective-cohort-study","The role of GP73 in predicting overall survival and chemotherapy response in locally advanced gastric cancer: a retrospective cohort study","","Gastric cancer remains a major cause of cancer mortality globally, with five-year survival still below 50% despite therapeutic advances. Standard management for locally advanced disease relies on curative gastrectomy combined with perioperative chemotherapy, yet treatment response varies and biomarkers are needed to guide individualized therapy. This retrospective study evaluates pretreatment GP73 expression in 92 patients receiving neoadjuvant chemotherapy and surgery. High GP73 correlates with poor tumor characteristics and worse overall survival, but shows no significant association with chemotherapy response.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-gp73-in-predicting-overall-survival-and-chemotherapy-response-in-locally-advanced-gastric-cancer-a-retrospective-cohort-study/356499/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-gp73-in-predicting-overall-survival-and-chemotherapy-response-in-locally-advanced-gastric-cancer-a-retrospective-cohort-study/356499.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study objective regarding GP73 in locally advanced gastric cancer?","Question",{"text":63,"@type":64},"To evaluate whether pretreatment GP73 expression is associated with overall survival and chemotherapy response in patients with locally advanced gastric cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was GP73 expression measured in this research?",{"text":68,"@type":64},"GP73 expression was assessed in pretreatment biopsy samples using immunohistochemistry.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings about prognosis and chemotherapy response?",{"text":72,"@type":64},"High pretreatment GP73 expression was linked to poorer tumor differentiation and worse overall survival, acting as an independent prognostic factor. However, GP73 expression did not show a significant correlation with chemotherapy response.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356499,1790944490,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Aliyev et al. BMCGastroenterology (2026) 26:180 [https://doi.org/10.1186/s12876-026-04713-9](https://doi.org/10.1186/s12876-026-04713-9)  \nBMC Gastroenterology  \nRESEARCH Open Access  \nThe role of GP73 in predicting overall survival and chemotherapy response in locally advanced gastric cancer: a retrospective cohort study  \nAltay Aliyev1*, Arturan Ibrahimli2, Johnn Henry Herrera Kok3, Elgun Samadov4, Farida Aghayarli1, Iqbal Babazade 1, Parvana Asgarova5, Adila Adilli6, Akbar Hajiyev6 and Jamal Musayev7,8  \nAbstract  \nBackground Gastric cancer (GC) is a leading cause of cancer-related mortality globally, with a 5-year survival rate remaining below 50% despite advancements in treatment. The standard care for locally advanced GC includes curative gastrectomy combined with perioperative chemotherapy. Different factors may influence chemotherapy responses, underscoring the need for biomarkers to tailor treatment. GP73, a Golgi-associated protein, has been implicated in cancer progression and prognosis, though its role in GC remains poorly understood. This study aimed to evaluate the association between pretreatment GP73 expression and overall survival (OS) and chemotherapy response in locally advanced GC patients.  \nMethods This was a retrospective study of 92 locally advanced GC patients who received neoadjuvant chemotherapy and underwent surgery between 2017 and 2024. GP73 expression was assessed in pretreatment biopsy samples via immunohistochemistry. Clinicopathological data were analyzed, and the correlation between GP73 expression and survival, as well as chemotherapy response, was evaluated. Tumor regression was graded using the Mandard Tumor Regression Grade scale. Continuous variables were demonstrated as median and interquartile range.  \nResults High GP73 expression was observed in 64% of patients and correlated with poor tumor differentiation and reduced likelihood of radical surgery. Univariate analysis revealed that high GP73 expression was significantly associated with poorer overall survival (p \u003C 0. 001) . Multivariate Cox model identified high GP73 status as an independent prognostic factor for poor OS (HR 4 . 53, p \u003C 0. 001) . However, no significant correlation was found between GP73 expression and chemotherapy response (p = 0 . 32) .  \nConclusions This study suggests that high pretreatment GP73 expression is a marker of poor prognosis in locally advanced GC, linked to poorer survival and less favorable tumor characteristics. These results highlight the need for  \n*Correspondence:  \nAltay Aliyev [draltayaliyev@gmail.com](draltayaliyev@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nAliyev et al. BMC Gastroenterology (2026) 26:180 Page 2 of 9  \npersonalized treatment strategies incorporating GP73 and other clinicopathological factors to optimize outcome","cbCaitFe9RuST1Ud","https://ap.wps.com/l/cbCaitFe9RuST1Ud","pdf",1630672,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background","[{\"question\":\"What was the study objective regarding GP73 in locally advanced gastric cancer?\",\"answer\":\"To evaluate whether pretreatment GP73 expression is associated with overall survival and chemotherapy response in patients with locally advanced gastric cancer.\"},{\"question\":\"How was GP73 expression measured in this research?\",\"answer\":\"GP73 expression was assessed in pretreatment biopsy samples using immunohistochemistry.\"},{\"question\":\"What were the main findings about prognosis and chemotherapy response?\",\"answer\":\"High pretreatment GP73 expression was linked to poorer tumor differentiation and worse overall survival, acting as an independent prognostic factor. However, GP73 expression did not show a significant correlation with chemotherapy response.\"}]","The role of GP73 in predicting overall survival and chemotherapy response in locally advanced gastric cancer: a retrospective cohort study | PDF",1790125617,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7ec392e41d89285b6a39895082b7e0e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43dff404e2db1b40008c54bf173f8bdc.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/610cace2b03af53a7f5800dec6349082.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5efcabdec5e064f5480c76f01dd0b78.webp",980,1306]